Quorum-Sensing Inhibition as a Novel Strategy for Controlling Bacterial Biofilms
Journal of Health, Wellness and Community Research · 30.03.2026 · 1-10
DOI: 10.61919/gy76nz55 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Health, Wellness and Community Research, online erschienen am 30.03.2026. Verfasst von Farah Danish und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Bacterial biofilms contribute to persistent and difficult-to-treat infections by protecting microorganisms from antimicrobial agents and host defenses. Quorum sensing (QS) regulates multiple biofilm- and virulence-associated behaviors and has therefore emerged as a potential anti-virulence target. Despite extensive experimental investigation, the translational relevance of QS inhibition remains uncertain because activity varies across organisms, signaling pathways, compounds, and experimental models.
Objective
To critically review, using a targeted narrative approach, the biological basis, experimental evidence, therapeutic potential, and translational limitations of quorum-sensing inhibition for controlling bacterial biofilms, with primary emphasis on developments reported between 2019 and 2024.
Methods
Published evidence concerning natural and synthetic QS inhibitors, quorum-quenching enzymes and bacteria, antibiotic-QSI combinations, resistance mechanisms, delivery strategies, and clinically relevant biofilm-forming pathogens was narratively synthesized. Experimental evidence addressing biofilm formation, QS-regulated virulence, signaling pathways, gene expression, and antimicrobial susceptibility was prioritized, with particular attention to Pseudomonas aeruginosa and Staphylococcus aureus. Evidence was interpreted according to experimental context and translational relevance; no meta-analysis was performed.
Results
Natural products, synthetic QS modulators, and enzymatic quorum-quenching strategies consistently altered one or more QS-regulated phenotypes in experimental systems. Three-hydroxybenzoic acid produced approximately 90% inhibition of S. aureus biofilm activity at 25 µg/mL, while SsoPox-W263I produced greater than 70% biofilm reduction in 6 of 10 evaluated P. aeruginosa clinical isolates. Quorum-quenching bacterial isolates produced approximately 50–60% biofilm reductions in selected multidrug-resistant P. aeruginosa isolates. Antibiotic-QSI combinations showed enhanced antimicrobial activity in experimental models, although human efficacy evidence remained limited.
Conclusion
QS inhibition is a promising adjunctive antibiofilm and anti-virulence strategy, but clinical translation requires standardized models, pharmacokinetic and toxicological validation, testing in diverse clinical isolates and mature biofilms, and appropriately designed clinical studies
Zitieren
APA
Danish, F., & Khan, N. (2026). Quorum-Sensing Inhibition as a Novel Strategy for Controlling Bacterial Biofilms. Journal of Health, Wellness and Community Research, 1-10. https://doi.org/10.61919/gy76nz55
Vancouver
Danish F, Khan N. Quorum-Sensing Inhibition as a Novel Strategy for Controlling Bacterial Biofilms. Journal of Health, Wellness and Community Research. 2026:1-10. doi:10.61919/gy76nz55
BibTeX
@article{Danish2026,
author = {Danish, Farah and Khan, Nimra},
title = {Quorum-Sensing Inhibition as a Novel Strategy for Controlling Bacterial Biofilms},
journal = {Journal of Health, Wellness and Community Research},
year = {2026},
pages = {1--10},
doi = {10.61919/gy76nz55}
}
EUVIMED